Introduction to clinical positron emission tomography.
Positron emission tomography (PET) scanning with [18F] fluorodeoxyglucose (FDG) has developed over 25 years into a valuable clinical tool used mainly for the evaluation of oncology patients. The purpose of this article is to provide an introduction to the basic scientific concepts of FDG-PET imaging as well as to illustrate its clinical utility.